LB Pharma

LB is a life sciences company focused on the clinical stage of the central nervous system, dedicated to commercializing novel and improved versions successfully used in CNS treatments that have been widely adopted overseas but never approved in the United States. LB-102, or N-methyl amisulpride, is the company’s leading clinical asset.